Cargando…
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated
Background: Sialorrhoea and drooling are disabling manifestations of different neurological disorders. The aim of this study was to evaluate the effects of botulinum neurotoxin type A (BoNT/A) injection on hypersalivation in 90 patients with neurological diseases of different aetiologies, and to def...
Autores principales: | Restivo, Domenico A., Panebianco, Mariangela, Casabona, Antonino, Lanza, Sara, Marchese-Ragona, Rosario, Patti, Francesco, Masiero, Stefano, Biondi, Antonio, Quartarone, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848156/ https://www.ncbi.nlm.nih.gov/pubmed/29382036 http://dx.doi.org/10.3390/toxins10020055 |
Ejemplares similares
-
Dysphagia in neurological diseases: a literature review
por: Panebianco, M., et al.
Publicado: (2020) -
Botulinum toxin therapy: functional silencing
of salivary disorders
por: Lovato, A., et al.
Publicado: (2017) -
Sialorrhoea and Ptyalomania
Publicado: (1914) -
An unusual complication of Botox treatment for sialorrhoea
por: Layton, Thomas Benjamin
Publicado: (2014) -
The burden of sialorrhoea in chronic neurological conditions: current
treatment options and the role of incobotulinumtoxinA (Xeomin®)
por: Morgante, Francesca, et al.
Publicado: (2019)